Literature DB >> 31044979

Optical quality comparison between laser ablated myopic eyes with centration on coaxially sighted corneal light reflex and on entrance pupil center.

Yongji Liu, Yan Wang.   

Abstract

This paper aims to compare the image quality between centration on the coaxially sighted corneal light reflex (CSCLR) and on the entrance pupil center (EPC). Myopic laser ablation was simulated on eye models, and the optical performances were compared. Centration on the EPC leads to higher wavefront aberrations and lower modulation transfer function. The two centration methods give nearly identical retinal images for angle kappa less than 5°. Because of less tissue removal, centration on the EPC is probably preferable for angle kappa less than 5°, but CSCLR centration may be preferable for angle kappa larger than 5°. The degree of tilt of the post-surgery anterior corneal surface explains the differences between the two methods.

Entities:  

Mesh:

Year:  2019        PMID: 31044979     DOI: 10.1364/JOSAA.36.00B103

Source DB:  PubMed          Journal:  J Opt Soc Am A Opt Image Sci Vis        ISSN: 1084-7529            Impact factor:   2.129


  3 in total

Review 1.  Clinical outcomes of corneal refractive surgery comparing centration on the corneal vertex with the pupil center: a meta-analysis.

Authors:  Jiamei Zhang; Yan Wang; Xiaoqin Chen; Wenjing Wu
Journal:  Int Ophthalmol       Date:  2020-07-15       Impact factor: 2.031

2.  The relationship between angle kappa and astigmatism after phacoemulsification with implanting of spherical and aspheric intraocular lens.

Authors:  Larysa Tutchenko; Sudi Patel; Mykhailo Skovron; Olha Horak; Oleksiy Voytsekhivskyy
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

3.  Translation model for CW chord to angle Alpha derived from a Monte-Carlo simulation based on raytracing.

Authors:  Achim Langenbucher; Nóra Szentmáry; Alan Cayless; Johannes Weisensee; Jascha Wendelstein; Peter Hoffmann
Journal:  PLoS One       Date:  2022-05-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.